Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 452567, 8 pages
http://dx.doi.org/10.1155/2009/452567
Review Article

Dermaseptins and Magainins: Antimicrobial Peptides from Frogs' Skin—New Sources for a Promising Spermicides Microbicides—A Mini Review

1Laboratory of Biochemistry, Faculty of Medicine, 4002 Sousse, Tunisia
2Institut Pasteur, Unité des Virus Lents, CNRS URA 1930, 75015 Paris, France

Received 4 December 2008; Accepted 17 August 2009

Academic Editor: Lori Snyder

Copyright © 2009 Amira Zairi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. J. D'Cruz and F. M. Uckun, “Clinical development of microbicides for the prevention of HIV infection,” Current Pharmaceutical Design, vol. 10, no. 30, pp. 315–336, 2004. View at Google Scholar
  2. I. M. Poynten, I. Y. Millwood, M. O. Falster et al., “The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies,” AIDS, vol. 23, no. 10, pp. 1245–1254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. CDCP update, “US HIV and AIDS cases reported through December 1996,” HIV/AIDS Surveillance Report 8; 1–33, 1997.
  4. J. Weber, A. Nunn, and O. Connor, “Chemical condoms for the prevention of HIV infection: evaluation of novel agents against SHIV (89.6 pd) in vitro and in vivo,” AIDS, vol. 15, no. 18, pp. 1563–1568, 2001. View at Google Scholar
  5. L. J. D. Zaneveld, R. A. Anderson, X.-H. Diao et al., “Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis,” Fertility and Sterility, vol. 78, no. 5, pp. 1107–1115, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. O. J. D'Cruz, T. K. Venkatachalam, and F. M. Uckun, “Structural requirements for potent human spermicidal activity of dual- function aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI- 07),” Biology of Reproduction, vol. 62, no. 1, pp. 37–44, 2000. View at Google Scholar · View at Scopus
  7. S. L. Hillier, T. Moench, R. Shattock, R. Black, P. Reichelderfer, and F. Veronese, “In vitro and in vivo: the story of nonoxynol 9,” Journal of Acquired Immuno Deficiency Syndromes, vol. 39, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. F. M. Uckun and O. J. D'Cruz, “Prophylactic contraceptives for HIV/AIDS,” Human Reproduction Update, vol. 5, no. 5, pp. 506–514, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Roddy, L. Zekeng, K. A. Ryan, U. Tamoufé, and K. G. Tweedy, “Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial,” Journal of the American Medical Association, vol. 287, no. 9, pp. 1117–1122, 2002. View at Google Scholar · View at Scopus
  10. O. J. D'Cruz and F. M. Uckun, “Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles,” Contraception, vol. 64, no. 2, pp. 113–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. C. Krebs, S. R. Miller, B. J. Catalone et al., “Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 7, pp. 1954–1960, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. I. J. Rosenstein, M. K. Stafford, V. S. Kitchen, H. Ward, J. N. Weber, and D. Taylor-Robinson, “Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1,” Journal of Infectious Diseases, vol. 177, no. 5, pp. 1386–1390, 1998. View at Google Scholar · View at Scopus
  13. M. K. Stafford, H. Ward, A. Flanagan et al., “Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects,” Journal of Acquired Immuno Deficiency Syndromes and Human Retrovirology, vol. 17, no. 4, pp. 327–331, 1998. View at Google Scholar · View at Scopus
  14. K. V. R. Reddy, R. D. Yedery, and C. Aranha, “Antimicrobial peptides: premises and promises,” International Journal of Antimicrobial Agents, vol. 24, no. 6, pp. 536–547, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Hultmark, “Drosophila immunity: paths and patterns,” Current Opinion in Immunology, vol. 15, no. 1, pp. 12–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Bals, “Epithelial antimicrobial peptides in host defense against infection,” Respiratory research, vol. 1, no. 3, pp. 141–150, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. K. L. Brown and R. E. Hancock, “Cationic host defense (antimicrobial) peptides,” Current Opinion in Immunology, vol. 18, no. 1, pp. 24–30, 2006. View at Google Scholar
  18. L. Zhang, W. Yu, T. He et al., “Contribution of human a-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor,” Science, vol. 298, no. 5595, pp. 995–1000, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Qu, S. L. Harwig, and A. Oren, “Susceptibilty of Neisseria gonorrhoeae to protegrins,” Infection and Immunity, vol. 65, pp. 636–639, 1996. View at Google Scholar
  20. B. Yasin, S. L. Harwig, R. I. Lehrer, and E. A. Wagar, “Susceptibility of Chlamydia trachomatis to protegrins and defensins,” Infection and Immunity, vol. 64, no. 3, pp. 709–713, 1996. View at Google Scholar
  21. K. E. Sutyak, R. A. Anderson, S. E. Dover et al., “Spermicidal activity of the safe natural antimicrobial peptide subtilosin,” Infectious Diseases in Obstetrics and Gynecology, vol. 2008, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Aranha, S. Gupta, and K. V. R. Reddy, “Contraceptive efficacy of antimicrobial peptide Nisin: in vitro and in vivo studies,” Contraception, vol. 69, no. 4, pp. 333–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Zasloff, B. Martin, and H.-C. Chen, “Antimicrobial activity of synthetic magainin peptides and several analogues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 3, pp. 910–913, 1988. View at Google Scholar · View at Scopus
  24. K. V. R. Reddy, S. K. Shahani, and P. K. Meherji, “Spermicidal activity of magainins: in vitro and in vivo studies,” Contraception, vol. 53, no. 4, pp. 205–210, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Zairi, F. Tangy, M. Ducos-Galand, J.-M. Alonso, and K. Hani, “Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives,” Diagnostic Microbiology and Infectious Disease, vol. 57, no. 3, pp. 319–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Zairi, F. Tangy, S. Saadi, and K. Hani, “In vitro activity of dermaseptin S4 derivatives against genital infections pathogens,” Regulatory Toxicology and Pharmacology, vol. 50, no. 3, pp. 353–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Zairi, A. Belaïd, A. Gahbiche, and K. Hani, “Spermicidal activity of dermaseptins,” Contraception, vol. 72, no. 6, pp. 447–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. H. Caporale, “Chance favors the prepared genome,” Annals of the New York Academy of Sciences, vol. 870, pp. 1–21, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Severini, G. Importa, V. Falconieri-Erspamer, S. Salvadori, and V. Erspamer, “The tachykinin peptide family,” Pharmacological Reviews, vol. 54, pp. 285–322, 2002. View at Google Scholar
  30. M. Simmaco, G. Mignogna, and D. Barra, “Antimicrobial peptides from amphiban skin: what they tell us?” Biopolymers, vol. 47, pp. 435–450, 1998. View at Google Scholar
  31. C. Lacombe, C. Cifuentes-Diaz, I. Dunia, M. Auber-Thomay, P. Nicolas, and M. Amiche, “Peptide secretion in the cutaneous glands of South American tree frog Phyllomedusa bicolor: an ultrastructural study,” European Journal of Cell Biology, vol. 79, no. 9, pp. 631–641, 2000. View at Google Scholar · View at Scopus
  32. L. Jacob and M. Zasloff, “Potential therapeutic applications of magainins and other antimicrobial agents of animal origin,” Ciba Foundation Symposium, vol. 186, pp. 197–223, 1994. View at Google Scholar · View at Scopus
  33. M. Zasloff, “Antimicrobial peptides in health and disease,” The New England Journal of Medicine, vol. 347, pp. 1151–1160, 2002. View at Google Scholar
  34. W. E. Dulleman and L. Trueb, Biology of Amphibians, John Hopkins University Press, London, UK, 25th edition, 1994.
  35. S. E. van Compernolle, R. J. Taylor, K. Oswald-Richter et al., “Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells,” Journal of Virology, vol. 79, no. 18, pp. 11598–11606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. G. Giovannini, L. Poulter, B. W. Gibson, and D. H. Williams, “Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones,” Biochemical Journal, vol. 243, no. 1, pp. 113–120, 1987. View at Google Scholar · View at Scopus
  37. M. Zasloff, “Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 15, pp. 5449–5453, 1987. View at Google Scholar · View at Scopus
  38. K. P. Sai, P. N. Reddy, and M. Babu, “Investigations on wound healing by using amphibian skin,” Indian Journal of Experimental Biology, vol. 33, no. 9, pp. 673–676, 1995. View at Google Scholar · View at Scopus
  39. A. Clara, D. D. Manjramkar, and V. K. Reddy, “Preclinical evaluation of magainin-A as a contraceptive antimicrobial agent,” Fertility and Sterility, vol. 81, no. 5, pp. 1357–1365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. V. C. Albiol Matanic and V. Castilla, “Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus,” International Journal of Antimicrobial Agents, vol. 23, no. 4, pp. 382–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Egal, M. Conrad, D. L. MacDonald, W. L. Maloy, M. Motley, and C. A. Genco, “Antiviral effects of synthetic membrane-active peptides on herpes simplex virus, type 1,” International Journal of Antimicrobial Agents, vol. 13, no. 1, pp. 57–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. V. R. K. Reddy and D. D. Manjramkar, “Evaluation of the antifertility effect of magainin-A in rabbits: in vitro and in vivo studies,” Fertility and Sterility, vol. 73, no. 2, pp. 353–358, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Zatuchni, D. W. Hahn, and L. J. D. Zaneveld, “Postcoital, vaginal, spermicidal potency of formulations: the Macaca arctoides (stumptailed macaque) as animal model,” Fertility and Sterility, vol. 35, no. 6, pp. 683–690, 1981. View at Google Scholar · View at Scopus
  44. A. Zairi, C. Serres, F. Tangy, P. Jouannet, and K. Hani, “In vitro spermicidal activity of peptides from amphibian skin: dermaseptin S4 and derivatives,” Bioorganic & Medicinal Chemistry, vol. 16, no. 1, pp. 266–275, 2008. View at Publisher · View at Google Scholar
  45. A. Mor and P. Nicolas, “Isolation and structure of novel defensive peptides from frog skin,” European Journal of Biochemistry, vol. 219, no. 1-2, pp. 145–154, 1994. View at Google Scholar · View at Scopus
  46. A. Mor, K. Hani, and P. Nicolas, “The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms,” The Journal of Biological Chemistry, vol. 269, no. 50, pp. 31635–31641, 1994. View at Google Scholar · View at Scopus
  47. O. Lequin, A. Ladram, L. Chabbert et al., “Dermaseptin S9, an a-helical antimicrobial peptide with a hydrophobic core and cationic termini,” Biochemistry, vol. 45, no. 2, pp. 468–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Navon-Venezia, R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor, “Antibacterial properties of dermaseptin S4 derivatives with in vivo activity,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 3, pp. 689–694, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Kustanovich, D. E. Shalev, M. Mikhlin, L. Gaidukov, and A. Mor, “Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives,” The Journal of Biological Chemistry, vol. 277, no. 19, pp. 16941–16951, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Feder, A. Dagan, and A. Mor, “Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerisation on selective cytotoxicity,” The Journal of Biological Chemistry, vol. 275, pp. 4230–4238, 2000. View at Google Scholar
  51. M. Krugliak, R. Feder, V. Y. Zolotarev et al., “Antimalarial activities of dermaseptin S4 derivatives,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 9, pp. 2442–2451, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. J. R. Naglik, S. J. Challacombe, and B. Hube, “Candida albicans secreted aspartyl proteinases in virulence and pathogenesis,” Microbiology and Molecular Biology Reviews, vol. 67, no. 3, pp. 400–428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Venev, “Experimental abortions in mice and guinea pigs caused by Aspergillus fumigatus spores,” Veterinarno-Meditsinski Nauki, vol. 13, no. 1, pp. 86–93, 1976. View at Google Scholar · View at Scopus
  54. C. Hernandez, A. Mor, F. Dagger et al., “Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin,” European Journal of Cell Biology, vol. 59, no. 2, pp. 414–424, 1992. View at Google Scholar · View at Scopus
  55. A. Dagan, L. Efron, L. Gaidukov, A. Mor, and H. Ginsburg, “In vitro antiplasmodium effects of dermaseptins,” Antimicrob Agents Chemother, vol. 46, pp. 1059–1066, 2002. View at Google Scholar
  56. L. Efron, A. Dagan, L. Gaidukov, H. Ginsburg, and A. Mor, “Direct interaction of dermaseptin S4 aminoheptanoyl derivate with intra-erythrocytic malaria parasite leading to increased specific antiparasitic activity in culture,” The Journal of Biological Chemistry, vol. 277, pp. 24067–24072, 2002. View at Google Scholar
  57. P. J. Coote, C. D. Holyoak, D. Bracey, D. P. Ferdinando, and J. A. Pearce, “Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 9, pp. 2160–2170, 1998. View at Google Scholar · View at Scopus
  58. C. Lorin, H. Saidi, A. Belaid, A. Zairi, F. Baleux, and H. Hocini, “The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro,” Virology, vol. 334, no. 2, pp. 264–275, 2005. View at Publisher · View at Google Scholar
  59. T. Rydlo, S. Sotem, and A. Mor, “Antibacterial 1 properties of dermaseptin S4 derivatives under extreme incubation conditions,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 2, pp. 490–507, 2006. View at Publisher · View at Google Scholar
  60. E. Andres and J. L. Dimarq, “Clinical development of antimicrobial peptides,” The International Journal of Antimicrobial Agents, vol. 25, pp. 448–449, 2005. View at Google Scholar
  61. O. Levy, “Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents,” Blood, vol. 96, no. 8, pp. 2664–2672, 2000. View at Google Scholar · View at Scopus
  62. T. Gura, “Innate immunity: ancient system gets new respect,” Science, vol. 291, no. 5511, pp. 2068–2071, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. D. W. Paquette, D. M. Simpson, P. Friden, V. Braman, and R. C. Williams, “Safety and clinical effects of topical histatin gels in humans with experimental gingivitis,” Journal of Clinical Periodontology, vol. 29, no. 12, pp. 1051–1058, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. R. E. W. Hancock, “Host defence (cationic) peptides. What is their future clinical potential?” Drugs, vol. 57, pp. 469–473, 1999. View at Google Scholar